Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pliant Therapeutics, Inc.

1.58
+0.12008.22%
Post-market: 1.610.0300+1.90%16:58 EDT
Volume:1.48M
Turnover:2.32M
Market Cap:96.99M
PE:-0.44
High:1.65
Open:1.45
Low:1.45
Close:1.46
Loading ...

Pliant Therapeutics Inc expected to post a loss of 70 cents a share - Earnings Preview

Reuters
·
01 Aug

When the market’s hot, go where it’s not: Biotech’s position of opportunity for FY26

LiveWire
·
15 Jul

Analysts Offer Insights on Healthcare Companies: BeiGene (ONC), Apellis Pharmaceuticals (APLS) and Pliant Therapeutics (PLRX)

TIPRANKS
·
02 Jul

Pliant Therapeutics Discontinues Bexotegrast Development in IPF Following BEACON-IPF Trial Review; Continues Oncology and Early-Stage Programs

Reuters
·
28 Jun

Pliant Therapeutics Approves Key Proposals at Annual Meeting

TIPRANKS
·
10 Jun

Pliant Therapeutics Inc. Held Annual Stockholders Meeting

Reuters
·
10 Jun

Piper Sandler Keeps Their Buy Rating on Pliant Therapeutics (PLRX)

TIPRANKS
·
09 May

Oppenheimer Sticks to Its Hold Rating for Pliant Therapeutics (PLRX)

TIPRANKS
·
09 May

Pliant Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
09 May

BRIEF-Pliant Therapeutics Q1 Net Income USD -56.166 Million

Reuters
·
09 May

Pliant Therapeutics to lay off 45% of Workforce in Restructuring Move

MT Newswires Live
·
02 May

Pliant Therapeutics Inc expected to post a loss of 72 cents a share - Earnings Preview

Reuters
·
02 May

Pliant Therapeutics Reduces Workforce as Part of Strategic Realignment

Dow Jones
·
02 May

Pliant Therapeutics to reduce workforce by 45%

TIPRANKS
·
02 May

Pliant Therapeutics Announces Strategic Realignment of Workforce and Operations

GlobeNewswire
·
02 May

PLIANT THERAPT (PLRX) Upgraded to Buy: Here's What You Should Know

Zacks
·
11 Apr

Pliant Therapeutics Signs Shareholder Rights Agreement

MT Newswires Live
·
13 Mar

Needham Downgrades Pliant Therapeutics to Hold From Buy

MT Newswires Live
·
04 Mar

Analysts Conflicted on These Healthcare Names: Pliant Therapeutics (PLRX) and Capricor Therapeutics (CAPR)

TIPRANKS
·
04 Mar

Pliant Therapeutics Cut to Hold From Buy by Needham

Dow Jones
·
04 Mar